Skip to main content
N.K.Industries Ltd. logo

N.K.Industries Ltd. — Investor Relations & Filings

Ticker · NKIND ISIN · INE542C01019 LEI · 335800H85IMF7BWWOG16 BSE.NS Manufacturing
Open in API
Filings indexed 797 across all filing types
Latest filing 2020-06-01 Regulatory Filings
Country IN India
Listing BSE.NS NKIND

About N.K.Industries Ltd.

https://www.nkindustriesltd.com/

N.K. Industries Ltd. specializes in the processing, refining, and export of castor oil and its diverse range of derivatives. The company operates integrated manufacturing facilities designed to produce high-quality castor oil grades, including British Standard Specification (BSS), First Special Grade (FSG), and commercial variants. Its product portfolio extends to value-added chemical derivatives such as 12-Hydroxy Stearic Acid (12-HSA), Hydrogenated Castor Oil (HCO), and Ricinoleic Acid. These products serve as essential raw materials across various global sectors, including lubricants, pharmaceuticals, cosmetics, paints, and polymers. The company focuses on maintaining technical standards and process efficiency to cater to both domestic and international industrial requirements.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-06-01 English
Outcome of Board Meeting
Regulatory Filings
2020-06-01 English
Audited Consolidated and Standalone Financial Results for the quarter and year ended on 31st March, 2020
Regulatory Filings
2020-06-01 English
Outcome of Board Meeting held today i.e. 1st June, 2020
Regulatory Filings
2020-06-01 English
Strikes/Lockouts/Disturbances
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the impact of the COVID-19 pandemic on the company's business. It references SEBI regulations and a SEBI advisory circular. The content discusses operational status, lease agreements, cost-cutting measures, and the uncertainty of financial impact. There are no financial statements, detailed financial data, or comprehensive report content. The document is relatively short (3364 characters) and serves as a regulatory disclosure update rather than a full report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement related to business impact and compliance with disclosure obligations under SEBI regulations. Therefore, it best fits the category of Regulatory Filings (RNS).
2020-05-29 English
Disclosure of impact of CoVID-19 pandemic on the business of the Company Under SEBI (LODR)Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the impact of the COVID-19 pandemic on the company's business. It references SEBI regulations and a SEBI circular, indicating it is a regulatory disclosure. The content discusses operational status, lease agreements, cost-cutting measures, and the uncertainty of financial impact but does not contain any financial statements or detailed financial data. The document length is 3364 characters, which is relatively short and primarily serves as an announcement or update rather than a full report. It does not present financial results, audit opinions, or detailed management analysis. Therefore, it fits best as a Regulatory Filing (RNS) since it is a compliance-related disclosure without substantive financial data or report content.
2020-05-29 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.